Agency Recommendations Aim to Inform Psychedelic Drug Development SILVER SPRING, Md., June 23, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.